These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 23625676)

  • 1. Nevirapine-induced Stevens-Johnson syndrome following HIV postexposure prophylaxis.
    Bannaga A; Rahama O; Barlow G
    BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23625676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-nucleoside reverse transcriptase inhibitors (NNRTIs)-induced Stevens-Johnson syndrome and gynecomastia in an HIV-infected child: A case report.
    Saka B; Akakpo AS; Bassowa A; Dapam AN; Mahamadou G; Teclessou JN; Mouhari-Toure A; Laouali AY; Mensah E; Kombaté K; Pitché P
    Ann Dermatol Venereol; 2018 Dec; 145(12):773-776. PubMed ID: 30301570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Toxic epidermal necrolysis in acquired immunodeficiency syndrome treated with intravenous gammaglobulin.
    Phan TG; Wong RC; Crotty K; Adelstein S
    Australas J Dermatol; 1999 Aug; 40(3):153-7. PubMed ID: 10439528
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nevirapine and the risk of Stevens-Johnson syndrome or toxic epidermal necrolysis.
    Fagot JP; Mockenhaupt M; Bouwes-Bavinck JN; Naldi L; Viboud C; Roujeau JC;
    AIDS; 2001 Sep; 15(14):1843-8. PubMed ID: 11579247
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nevirapine-associated Stevens-Johnson syndrome.
    Warren KJ; Boxwell DE; Kim NY; Drolet BA
    Lancet; 1998 Feb; 351(9102):567. PubMed ID: 9492778
    [No Abstract]   [Full Text] [Related]  

  • 6. Nevirapine and/or co-trimoxazole induced Stevens Johnson syndrome in HIV infected patient--a case report.
    Patel K; Panchasara A; Purohit B; Tripathi CB
    Curr Drug Saf; 2013 Feb; 8(1):72-4. PubMed ID: 23656450
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nevirapine-induced Stevens-Johnson syndrome in a pediatric patient.
    Mason AR; Cortes GY; Pollack RB
    Pediatr Dermatol; 2008; 25(1):128-9. PubMed ID: 18304177
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stevens-Johnson syndrome in HIV patients treated with nevirapine: two case reports.
    Dodi F; Alessandrini A; Camera M; Gaffuri L; Morandi N; Pagano G
    AIDS; 2002 May; 16(8):1197-8. PubMed ID: 12004287
    [No Abstract]   [Full Text] [Related]  

  • 9. [Stevens-Johnson syndrome due to nevirapine].
    García Fernández D; García-Patos Briones V; Mollet Sánchez J; Castells Rodellas A
    Rev Clin Esp; 2000 Mar; 200(3):179-80. PubMed ID: 10804771
    [No Abstract]   [Full Text] [Related]  

  • 10. Nevirapine-induced Stevens-Johnson syndrome in a mother and son.
    Liechty CA; Solberg P; Mwima G; Were W; Weidle PJ; Mermin J
    AIDS; 2005 Jun; 19(9):993-4. PubMed ID: 15905686
    [No Abstract]   [Full Text] [Related]  

  • 11. [Toxic epidermal necrolysis associated with abacavir].
    Montero M; García-Gibert L; Giménez-Arnau AM; Knobel H
    Enferm Infecc Microbiol Clin; 2005 Apr; 23(4):247. PubMed ID: 15826554
    [No Abstract]   [Full Text] [Related]  

  • 12. From the Centers for Disease Control and Prevention. Serious adverse events attributed to nevirapine regimens for postexposure prophylaxis after HIV exposures--worldwide, 1997-2000.
    JAMA; 2001 Jan 24-31; 285(4):402-3. PubMed ID: 11263401
    [No Abstract]   [Full Text] [Related]  

  • 13. Severe hepatic and cutaneous adverse effects with nevirapine.
    Prescrire Int; 2000 Aug; 9(48):116. PubMed ID: 11067724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers.
    Johnson S; Baraboutis JG
    JAMA; 2000 Dec; 284(21):2722-3. PubMed ID: 11105175
    [No Abstract]   [Full Text] [Related]  

  • 15. Nevirapine-induced Stevens-Johnson syndrome in an HIV patient.
    Jain V; Shome D; Natarajan S
    Cornea; 2008 Apr; 27(3):366-7. PubMed ID: 18362670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Recurrence of Stevens-Johnson syndrome following erroneous readministration of nevirapine].
    Kombaté K; Saka B; Mouhari-Toure A; Gnassingbé W; Akakpo S; Aho K; Tchangaï-Walla K; Pitché P
    Ann Dermatol Venereol; 2015 May; 142(5):367-8. PubMed ID: 25683010
    [No Abstract]   [Full Text] [Related]  

  • 17. [Exanthema in a patient infected with the human immunodeficiency virus after starting antiretroviral treatment].
    Palacios Muñoz R; Santos González J; Bosch García R; Márquez Solero M
    Rev Clin Esp; 2000 Nov; 200(11):635-6. PubMed ID: 11196597
    [No Abstract]   [Full Text] [Related]  

  • 18. Adverse effects associated with use of nevirapine in HIV postexposure prophylaxis for 2 health care workers.
    Sha BE; Proia LA; Kessler HA
    JAMA; 2000 Dec; 284(21):2723. PubMed ID: 11105176
    [No Abstract]   [Full Text] [Related]  

  • 19. Stevens-Johnson syndrome caused by the antiretroviral drug nevirapine.
    Metry DW; Lahart CJ; Farmer KL; Hebert AA
    J Am Acad Dermatol; 2001 Feb; 44(2 Suppl):354-7. PubMed ID: 11174414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desensitization to Nevirapine.
    TreatmentUpdate; 1999 Nov; 11(8):5. PubMed ID: 11367044
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.